A second Australian IVF company wil float on the stock exchange today.
A second Australian IVF company wil float on the stock exchange today. Investment analysts believe that Monash IVF will have a market capitalisation of about A$427 million. Its rival, Virtus Health, is capitalised at $694 million. This means that Australian IVF is at least a $1 billion business. As capital markets expert Paul Docherty explains in this interview in The Conversation, IVF is an attractive investment for institutional investors in Australia because it helps them to diversify their portfolio.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021